06 Feb 2007 |
SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-801i in Age-Related Macular Degeneration (AMD)
|
03 Feb 2007 |
Genta Completes Response to EMEA List of Outstanding Issues for Genasense® Marketing Authorization Application in Melanoma
|
02 Feb 2007 |
Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
|
30 Jan 2007 |
LCT to start clinical trial of type 1 diabetes treatment
|
30 Jan 2007 |
Advanced Viral Begins Phase II Dermatological Study
|
26 Jan 2007 |
Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application
|
25 Jan 2007 |
Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
|
23 Jan 2007 |
iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema
|
23 Jan 2007 |
Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
|
19 Jan 2007 |
Targeted Genetics Announces Publication of Inflammatory Arthritis Study in Molecular Therapy
|
18 Jan 2007 |
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
|
18 Jan 2007 |
Studies Show Geron's Stem Cell Therapeutic For Spinal Cord Injury Produces Nerve Growth Factors
|
18 Jan 2007 |
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
|
17 Jan 2007 |
Gentium Receives Orphan Drug Designation from FDA for Defibrotide to Prevent Hepatic Veno-occlusive Disease
|
16 Jan 2007 |
Osiris Therapeutics Receives European Orphan Drug Designation for PROCHYMAL
|
13 Jan 2007 |
ReNeuron provides a further update on the IND application for ReN001
|
12 Jan 2007 |
Ark Holds Positive End of Phase II Meeting with FDA on Trinam(R) Gene Therapy
|
12 Jan 2007 |
Genvec Receives Clearance From FDA For Eus Administration Of TNFerade
|
12 Jan 2007 |
Takara Bio Obtains Clinical Trial Approval of Gene Therapy Treatment for Chronic Granulomatosis
|
10 Jan 2007 |
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
|
10 Jan 2007 |
Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
|
10 Jan 2007 |
Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
|
09 Jan 2007 |
Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn’s Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
|
09 Jan 2007 |
ProNAi Announces Dna Interference (DNAI(R)) Drug Development Strategy For 2007
|
06 Jan 2007 |
Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
|